Endo Shares Outstanding 2006-2020 | ENDP

Endo shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Endo Annual Shares Outstanding
(Millions of Shares)
2019 226
2018 224
2017 223
2016 223
2015 197
2014 157
2013 120
2012 116
2011 121
2010 118
2009 118
2008 124
2007 135
2006 134
2005 133
Endo Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 230
2020-06-30 234
2020-03-31 233
2019-12-31 226
2019-09-30 227
2019-06-30 226
2019-03-31 225
2018-12-31 224
2018-09-30 224
2018-06-30 224
2018-03-31 224
2017-12-31 223
2017-09-30 223
2017-06-30 223
2017-03-31 223
2016-12-31 223
2016-09-30 223
2016-06-30 223
2016-03-31 222
2015-12-31 197
2015-09-30 209
2015-06-30 185
2015-03-31 177
2014-12-31 157
2014-09-30 159
2014-06-30 163
2014-03-31 128
2013-12-31 120
2013-09-30 120
2013-06-30 117
2013-03-31 113
2012-12-31 116
2012-09-30 120
2012-06-30 121
2012-03-31 117
2011-12-31 121
2011-09-30 121
2011-06-30 123
2011-03-31 121
2010-12-31 118
2010-09-30 117
2010-06-30 117
2010-03-31 118
2009-12-31 118
2009-09-30 118
2009-06-30 117
2009-03-31 117
2008-12-31 124
2008-09-30 120
2008-06-30 124
2008-03-31 135
2007-12-31 135
2007-09-30 135
2007-06-30 135
2007-03-31 134
2006-12-31 134
2006-09-30 134
2006-06-30 134
2006-03-31 134
2005-12-31 133
2005-09-30 134
2005-06-30 133
2005-03-31 133
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.663B $2.914B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.970B 41.96
Takeda Pharmaceutical (TAK) Japan $56.939B 10.62
Astellas Pharma (ALPMY) Japan $29.602B 18.49
Merck (MKGAF) Germany $22.933B 0.00
Eisai (ESALY) Japan $21.762B 18.96
UCB SA (UCBJF) Belgium $20.831B 0.00
Catalent (CTLT) United States $18.899B 56.53
Grifols, S.A (GRFS) Spain $13.235B 15.16
Neurocrine Biosciences (NBIX) United States $10.104B 79.52
Jazz Pharmaceuticals (JAZZ) Ireland $9.081B 14.67
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.772B 0.00
Ionis Pharmaceuticals (IONS) United States $8.340B 81.71
Arrowhead Pharmaceuticals (ARWR) United States $8.323B 0.00
United Therapeutics (UTHR) United States $7.204B 15.34
IPSEN SA ADR (IPSEY) France $7.040B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.853B 396.78
Sage Therapeutics (SAGE) United States $5.008B 0.00
PTC Therapeutics (PTCT) United States $4.547B 0.00
ChemoCentryx (CCXI) United States $4.271B 0.00
Hypermarcas (HYPMY) Brazil $4.117B 15.12
Cronos Group (CRON) Canada $3.807B 0.00
FibroGen (FGEN) United States $3.581B 0.00
Nektar Therapeutics (NKTR) United States $3.288B 0.00
Pacira BioSciences (PCRX) United States $3.193B 69.33
Corcept Therapeutics (CORT) United States $3.133B 30.30
Taro Pharmaceutical Industries (TARO) Israel $2.946B 15.04
Xencor (XNCR) United States $2.754B 0.00
Revolution Medicines (RVMD) United States $2.540B 0.00
Tilray (TLRY) Canada $2.006B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.804B 15.44
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.758B 0.00
Translate Bio (TBIO) United States $1.706B 0.00
USANA Health Sciences (USNA) United States $1.660B 14.61
Heron Therapeutics (HRTX) United States $1.650B 0.00
Ocular Therapeutix (OCUL) United States $1.617B 0.00
Trillium Therapeutics (TRIL) Canada $1.465B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.439B 0.00
ImmunoGen (IMGN) United States $1.423B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.421B 9.88
Karyopharm Therapeutics (KPTI) United States $1.112B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.108B 0.00
Zogenix (ZGNX) United States $1.057B 0.00
Radius Health (RDUS) United States $1.029B 0.00
Indivior (INVVY) United States $1.029B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.937B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Acutus Medical (AFIB) United States $0.794B 0.00
ORGANOGENESIS (ORGO) United States $0.791B 0.00
Collegium Pharmaceutical (COLL) United States $0.755B 44.55
Esperion Therapeutics (ESPR) United States $0.750B 0.00
VAXART, INC (VXRT) United States $0.742B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.719B 0.00
Aerie Pharmaceuticals (AERI) United States $0.668B 0.00
Chinook Therapeutics (KDNY) United States $0.652B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.634B 0.00
Ardelyx (ARDX) United States $0.626B 0.00
Flexion Therapeutics (FLXN) United States $0.580B 0.00
Siga Technologies (SIGA) United States $0.564B 15.85
Harpoon Therapeutics (HARP) United States $0.540B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.536B 0.00
Molecular Templates (MTEM) United States $0.533B 0.00
PROFOUND MEDICL (PROF) Canada $0.472B 0.00
Sundial Growers (SNDL) Canada $0.465B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Altimmune (ALT) United States $0.453B 0.00
Akebia Therapeutics (AKBA) United States $0.450B 0.00
Summit Therapeutics (SMMT) United States $0.436B 0.00
TherapeuticsMD (TXMD) United States $0.426B 0.00
DURECT (DRRX) United States $0.423B 0.00
CASI Pharmaceuticals (CASI) United States $0.404B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.391B 0.00
Rafael Holdings (RFL) United States $0.381B 0.00
Concert Pharmaceuticals (CNCE) United States $0.375B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 9.51
Matinas Biopharma Holdings (MTNB) United States $0.321B 0.00
MEI Pharma (MEIP) United States $0.316B 0.00
Alpine Immune Sciences (ALPN) United States $0.315B 0.00
Nature's Sunshine Products (NATR) United States $0.299B 19.23
Jaguar Animal Health (JAGX) United States $0.297B 0.00
KalVista Pharmaceuticals (KALV) United States $0.294B 0.00
Jounce Therapeutics (JNCE) United States $0.292B 0.00
Redhill Biopharma (RDHL) Israel $0.282B 0.00
Xeris Pharmaceuticals (XERS) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.280B 7.37
Menlo Therapeutics (VYNE) United States $0.274B 0.00
Otonomy (OTIC) United States $0.271B 0.00
Aclaris Therapeutics (ACRS) United States $0.252B 0.00
CTI BioPharma (CTIC) United States $0.249B 0.00
OptiNose (OPTN) United States $0.222B 0.00
IMV INC (IMV) Canada $0.221B 0.00
Calithera Biosciences (CALA) United States $0.212B 0.00
Oncternal Therapeutics (ONCT) United States $0.199B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
ProPhase Labs (PRPH) United States $0.182B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Aquestive Therapeutics (AQST) United States $0.178B 0.00
Infinity Pharmaceuticals (INFI) United States $0.171B 0.00
Taiwan Liposome (TLC) Taiwan $0.167B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.161B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.159B 0.00
IsoRay (ISR) United States $0.156B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.148B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Heat Biologics (HTBX) United States $0.138B 0.00
Novan (NOVN) United States $0.137B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.135B 0.00
MediWound (MDWD) Israel $0.132B 0.00
Onconova Therapeutics (ONTX) United States $0.126B 0.00
Lipocine (LPCN) United States $0.101B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Nutriband (NTRB) United States $0.097B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.093B 0.00
SCYNEXIS (SCYX) United States $0.084B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.079B 153.00
ElectroCore (ECOR) United States $0.076B 0.00
Biomerica (BMRA) United States $0.074B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.072B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.071B 0.00
Recro Pharma (REPH) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.068B 0.00
India Globalization Capital (IGC) United States $0.067B 0.00
AgeX Therapeutics (AGE) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Vical (BBI) United States $0.060B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
Iterum Therapeutics (ITRM) Ireland $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.77
Regulus Therapeutics (RGLS) United States $0.046B 0.00
PolarityTE (PTE) United States $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.58
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.030B 0.00
KemPharm (KMPH) United States $0.027B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Flex Pharma (SLRX) United States $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 33.00
Bellicum Pharmaceuticals (BLCM) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00